Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar supez2004 (72.52) Submitted: 3/3/2008 1:08:22 AM : Outperform Start Price: $32.04 AUXL Score: -43.27

Xiaflex has potential to be a blockbuster drug in a niche market without many competitors ...

Featured Broker Partners


Advertisement